The p38 mitogen-activated protein kinase inhibitor, SB203580, activates the serine/threonine kinase Raf-1 in vascular smooth muscle cells.

被引：0
|
作者：
Daum, G [1 ]
Kalmes, A [1 ]
Clowes, AW [1 ]
机构：
[1] Univ Washington, Dept Surg, Seattle, WA 98195 USA
来源：
FASEB JOURNAL | 1999年 / 13卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A470 / A470
页数：1
相关论文
共 50 条
  • [1] Raf-1 is activated by the p38 mitogen-activated protein kinase inhibitor, SB203580
    Kalmes, A
    Deou, J
    Clowes, AW
    Daum, G
    FEBS LETTERS, 1999, 444 (01) : 71 - 74
  • [2] Thrombin activates p38 mitogen-activated protein kinase in vascular smooth muscle cells
    Kanda, Y
    Nishio, E
    Kuroki, Y
    Mizuno, K
    Watanabe, Y
    LIFE SCIENCES, 2001, 68 (17) : 1989 - 2000
  • [3] Preclinical pharmacokinetics of SB-203580, a potent inhibitor of p38 mitogen-activated protein kinase
    Ward, KW
    Proksch, JW
    Azzarano, LM
    Mumaw, JA
    Roethke, TJ
    Stelman, GJ
    Walsh, MJ
    Zeigler, KS
    McSurdy-Freed, JE
    Kehler, JR
    Chokshi, J
    Levy, MA
    Smith, BR
    XENOBIOTICA, 2001, 31 (11) : 783 - 797
  • [4] Quantitative proteomic and transcriptional analysis of the response to the p38 mitogen-activated protein kinase inhibitor SB203580 in transformed follicular lymphoma cells
    Lin, ZS
    Crockett, DK
    Jenson, SD
    Lim, MS
    Elenitoba-Johnson, KSJ
    MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (08) : 820 - 833
  • [5] Differential regulation of mast cell cytokines by both dexamethasone and the p38 mitogen-activated protein kinase (MAPK) inhibitor SB203580
    Koranteng, RD
    Swindle, EJ
    Davis, BJ
    Dearman, RJ
    Kimber, I
    Flanagan, BF
    Coleman, JW
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 137 (01): : 81 - 87
  • [6] P38 mitogen-activated protein kinase inhibitor SB203580 has a bi-directional effect on iNOS expression and NO production
    Lahti, A
    Kankaanranta, H
    Moilanen, E
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 454 (2-3) : 115 - 123
  • [7] p38 mitogen activated protein kinase inhibitor SB203580 attenuate the mechanical allodynia in neuropathic pain model.
    Mizokoshi, A
    Tsuda, M
    Shigemoto-Mogami, Y
    Koizumi, S
    Inoue, K
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 91 : 187P - 187P
  • [8] p38 mitogen-activated protein kinase expression and activation in smooth muscle
    Hedges, JC
    Yamboliev, IA
    Ngo, M
    Horowitz, B
    Adam, LP
    Gerthoffer, WT
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1998, 275 (02): : C527 - C534
  • [9] Pyridinylimidazole compound SB 203580 inhibits the activity but not the activation of p38 mitogen-activated protein kinase
    Kumar, S
    Jiang, MS
    Adams, JL
    Lee, JC
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 263 (03) : 825 - 831
  • [10] SB203580, the p38 mitogen-activated protein kinase inhibitor blocks the inhibitory effect of β-amyloid on long-term potentiation in the rat hippocampus
    Saleshando, G
    O'Connor, JJ
    NEUROSCIENCE LETTERS, 2000, 288 (02) : 119 - 122
12345